It’s being claimed a study by researchers in Switzerland found COVID-19 vaccines cause myocarditis in one in 35 people.
This is false. The study found one in 35 participants reported levels of elevated troponin, which is not the same as having the inflammatory heart disease.
One Facebook post (archived here) states: “Switzerland: a study was done on people about to receive a booster. They were tested before, and 3 days after for signs of heart damage. 1 in 35 (2.8%) had blood test results showing heart damage (myocarditis) 3 days after the booster. They were warned not to exercise until the issue resolved. I bet you can guess which vaccine.”
“It can be used as an assessment of the degree of heart injury that occurs,” Dr Schaffner told AAP FactCheck, with a high concentration indicating a possible heart condition.
Participants were only tested for troponin levels after receiving the vaccine, not before.
Elevated troponin was detected in 40 cases, but the researchers excluded 18 because an alternative cause other than vaccination was most likely (page 4).
This left 22 participants – 2.8 per cent of the group, or one in 35 – without an explanation for elevated troponin other than receiving a booster dose three days prior.
“2.8 per cent of people had a troponin level slightly above the normal range after receiving the vaccine, but these participants did not report symptoms suggestive of myocarditis any more often than people with troponin levels in the normal range,” he told AAP FactCheck in an email.
“This study also does not prove that the vaccine caused the increased troponin levels in those 2.8 per cent of people… To know whether or not the vaccine caused the troponin levels would need people to be randomised to receive the vaccine or not.”
Leslie Cooper, chair of the Department of Cardiovascular Medicine at the Mayo Clinic and an expert on myocarditis, said the study reported a slight elevation in “high sensitivity troponin which in and of itself may not reflect myocarditis.”
“There was no increase in clinical symptoms or documented imaging findings to correlate with the elevation in troponin,” Dr Cooper told AAP FactCheck.
The study’s co-author, Professor Christian Müller, referred AAP FactCheck to the paper’s discussion section (page 7), but said “as very often on this topic, many massively over-interpret it and others completely ignore the findings”.
The study notes “all cases were mild with only a transient and short period of myocardial injury” with the highest troponin concentration recorded among the participants being 35ng/L (page 7).
It concludes “no definitive case of myocarditis was found” (page 6).
Prof Schaffner noted there was a recognised small increased risk in clinical myocarditis after COVID-19 vaccination.
“If you get COVID the risk of myocarditis is many times higher than the risk after (the) vaccine.”
The claim a Swiss study found one in 35 people developed myocarditis after receiving a COVID-19 booster vaccine is false.
The study found 22 out of 777 participants reported elevated troponin, which can be associated with the heart disease, where a cause other than vaccination could not be determined. However, no definitive cases of myocarditis were discovered.
Experts told AAP FactCheck elevated troponin was not necessarily myocarditis and no other tests were done to confirm a clinical diagnosis.
False – The claim is inaccurate.